Compare STRIDES PHARMA SCIENCE with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs ORCHID PHARMA LTD - Comparison Results

STRIDES PHARMA SCIENCE     Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES PHARMA SCIENCE ORCHID PHARMA LTD STRIDES PHARMA SCIENCE/
ORCHID PHARMA LTD
 
P/E (TTM) x 16.1 -0.5 - View Chart
P/BV x 1.0 0.1 808.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 STRIDES PHARMA SCIENCE   ORCHID PHARMA LTD
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-18
ORCHID PHARMA LTD
Sep-13
STRIDES PHARMA SCIENCE/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,147194 591.2%   
Low Rs64235 1,834.3%   
Sales per share (Unadj.) Rs317.2276.5 114.8%  
Earnings per share (Unadj.) Rs7.8-79.2 -9.9%  
Cash flow per share (Unadj.) Rs25.1-43.5 -57.7%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs274.353.9 508.5%  
Shares outstanding (eoy) m89.5070.45 127.0%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x2.80.4 680.8%   
Avg P/E ratio x114.0-1.4 -7,888.2%  
P/CF ratio (eoy) x35.7-2.6 -1,354.8%  
Price / Book Value ratio x3.32.1 153.6%  
Dividend payout %25.50-   
Avg Mkt Cap Rs m80,0588,067 992.5%   
No. of employees `0002.52.8 89.5%   
Total wages/salary Rs m4,3412,527 171.8%   
Avg. sales/employee Rs Th11,325.86,956.1 162.8%   
Avg. wages/employee Rs Th1,731.4902.5 191.8%   
Avg. net profit/employee Rs Th280.1-1,993.0 -14.1%   
INCOME DATA
Net Sales Rs m28,39419,477 145.8%  
Other income Rs m941407 231.0%   
Total revenues Rs m29,33419,884 147.5%   
Gross profit Rs m3,9651,103 359.6%  
Depreciation Rs m1,5402,519 61.1%   
Interest Rs m1,9625,227 37.5%   
Profit before tax Rs m1,403-6,236 -22.5%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-1680-   
Extraordinary Inc (Exp) Rs m-436511 -85.3%   
Tax Rs m97-125 -77.7%   
Profit after tax Rs m702-5,580 -12.6%  
Gross profit margin %14.05.7 246.7%  
Effective tax rate %6.92.0 345.4%   
Net profit margin %2.5-28.7 -8.6%  
BALANCE SHEET DATA
Current assets Rs m24,83611,014 225.5%   
Current liabilities Rs m18,99332,060 59.2%   
Net working cap to sales %20.6-108.1 -19.0%  
Current ratio x1.30.3 380.6%  
Inventory Days Days7195 74.8%  
Debtors Days Days11334 338.0%  
Net fixed assets Rs m34,28929,440 116.5%   
Share capital Rs m895705 127.0%   
"Free" reserves Rs m23,6512,043 1,157.9%   
Net worth Rs m24,5463,800 646.0%   
Long term debt Rs m15,5139,018 172.0%   
Total assets Rs m65,43746,510 140.7%  
Interest coverage x1.7-0.2 -888.1%   
Debt to equity ratio x0.62.4 26.6%  
Sales to assets ratio x0.40.4 103.6%   
Return on assets %4.1-0.8 -535.7%  
Return on equity %2.9-146.9 -1.9%  
Return on capital %6.9-3.7 -184.6%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m15,6977,513 208.9%   
Fx outflow Rs m7355,649 13.0%   
Net fx Rs m14,9621,865 802.5%   
CASH FLOW
From Operations Rs m1,8711,682 111.2%  
From Investments Rs m5,826-9,860 -59.1%  
From Financial Activity Rs m-10,1576,644 -152.9%  
Net Cashflow Rs m-2,615-1,535 170.4%  

Share Holding

Indian Promoters % 27.7 32.3 85.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 4.6 821.7%  
FIIs % 8.6 3.3 260.6%  
ADR/GDR % 0.0 4.6 -  
Free float % 25.9 55.3 46.8%  
Shareholders   56,241 84,811 66.3%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES PHARMA SCIENCE With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  GLENMARK PHARMA  

Compare STRIDES PHARMA SCIENCE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Sep 13, 2019 (Close)

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 5-YR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS